Rashi Peripherals Ltd.

Shares of Rashi Peripherals, an ICT products distributor, jumped 3% on their debut trade, closing at Rs 320.60. The IPO had been subscribed 59.71 times earlier this month.

Rashi Peripherals shares listed on the stock market with a 9.16% premium over the issue price. The IPO was oversubscribed 59.71 times and raised Rs 600 crore.

Rashi Peripherals IPO received 59.71 times subscription on the final day, with QIBs subscribing 143.66 times. Learn more about the IPO details and performance.

Rashi Peripherals' IPO received 3.19 times subscription on Day 2, with strong interest from retail and institutional investors. Learn more about the IPO details, subscription status, and key...

Rashi Peripherals IPO received bids for 1.08 times the shares on offer on Day 1, with strong subscription from non-institutional investors and retail investors.

NSE MD & CEO Ashish Chauhan refutes rumors of him being considered for Tata Sons Chairman, reaffirming his commitment to NSE and its ongoing IPO process.

Commerce Minister Piyush Goyal calls for increased investment in pharma clinical trials & R&D, urging resilient supply chains & regulatory reforms for global competitiveness.

The 57th GST Council meeting is postponed to October 7 due to the BRICS summit. Discussions will include simplifying GST registration and cancellation procedures.

Analysts predict US inflation data, crude oil prices, and geopolitical tensions in West Asia will be key drivers for gold and silver markets this week.

Svitzer MD emphasizes viable commercial models for green towage adoption. High capital costs and charging infrastructure are key challenges for ports and operators.

NSE MD & CEO Ashish Chauhan refutes rumors of him being considered for Tata Sons Chairman, reaffirming his commitment to NSE and its ongoing IPO process.

Delhi government held a roundtable with startup leaders to strengthen its 2026 Startup Policy, aiming for 10,000+ startups & 4 lakh jobs. Discussions covered funding & support.

Commerce Minister Piyush Goyal calls for increased investment in pharma clinical trials & R&D, urging resilient supply chains & regulatory reforms for global competitiveness.

Bengal Chemicals proposes a Rs 150 crore anti-snake venom plant in West Bengal after 15 years, addressing high snake bite incidence and reducing reliance on external supplies.

The 57th GST Council meeting is postponed to October 7 due to the BRICS summit. Discussions will include simplifying GST registration and cancellation procedures.